|
|
| (9 intermediate revisions by 3 users not shown) |
| Line 1: |
Line 1: |
| | {{:Team:EPF_Lausanne/Top_Nav}} | | {{:Team:EPF_Lausanne/Top_Nav}} |
| − | <html> | + | <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr"> |
| − | <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"-->
| + | |
| − | | + | |
| − | <head>
| + | |
| − | | + | |
| − | <style>
| + | |
| − | h5{
| + | |
| − | font-weight: 600 ! important;
| + | |
| − | }
| + | |
| − | </style>
| + | |
| − | | + | |
| − | <head>
| + | |
| − | | + | |
| | <body> | | <body> |
| | | | |
| − | <div class="classy-bar"> | + | <div class=" carousel slide" id=" carousel-home"> |
| − | <div class="container">
| + | <div class="carousel-inner"> |
| − | <div class="row">
| + | <div class="item active"> |
| − | <div class="col-md-12 text-center"> | + | <img class="img-responsive center-block" src="https://static.igem.org/mediawiki/2015/4/4b/EPF_Lausanne_Home1.png" alt="First slide"> |
| − | <h2>Modeling</h2> | + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | | + | |
| − | <div class="container"> | + | |
| − | <ul class="nav nav-tabs nav-justified">
| + | |
| − | <li class="active"><a data-toggle="tab" href="#Intro">Introduction</a></li>
| + | |
| − | <li><a data-toggle="tab" href="#Bind">Binding</a></li>
| + | |
| − | <li><a data-toggle="tab" href="#Ass">Assumptions</a></li>
| + | |
| − | <li><a data-toggle="tab" href="#Eq">Equations</a></li>
| + | |
| − | <li><a data-toggle="tab" href="#Cst">Constants</a></li>
| + | |
| − | <li><a data-toggle="tab" href="#Sim">Results</a></li>
| + | |
| − | <li><a data-toggle="tab" href="#Ref">References</a></li>
| + | |
| − | </ul>
| + | |
| − | | + | |
| − | <div class="tab-content background-section">
| + | |
| − | <div id="Intro" class="tab-pane fade in active">
| + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-10 col-md-offset-1 text-justify">
| + | |
| − | <h3>Introduction</h3>
| + | |
| − | <p>In our project, multiple transistor elements are assembled to create logic gates. We envision the chaining of such gates in order to create complex logic circuits within cells. Predicting the behaviour of these complex cascades of reactions and way they reach a stationary state can be challenging. Modeling here represents the best way to understand our system and quantify the influence of various biochemical parameters. On the long run, modeling may also help fine-tune the design of biological systems and wet lab experiments.</p>
| + | |
| − | | + | |
| − | <p>Since the wet lab is normally accessible only during the summer at full time for each university, the time is very limited. Our team were able to build a solid proof of concept of a new way of building logic circuits using dCas9, but creating a whole complex cuircuit wuold require more time. However, a good model (tuned on the experiment we performed for single transistors) allows the design and the study of complex circuits in silico.</p>
| + | |
| − | | + | |
| − | <p>We attempted to model the dynamics and interactions our system's components to predict the temporal response of our biological circuits. In order to achieve a good description we initially used the powerful tools of statistical mechanics in order to generalize Hill's description of ligand-receptor binding [1] taking into account independent or exclusive binding of two dCas9 to the same promoter. This statistical view of regulatory dynamic is then used, following the same steps of the simple ligand-receptor binding, to write kinetic equations.</p>
| + | |
| − | | + | |
| − | <p>Kinetic equations forms a system of ODEs which is solved numerically and fitted to some experimental data, in order to describe the actual dynamic of the system. We found that our model considered at the steady state is able to satisfactory describe experimental results and can be used to predict the output of compelx logic circuits.</p>
| + | |
| | </div> | | </div> |
| − | </div>
| + | <div class="item"> |
| − | </div>
| + | <img class="img-responsive center-block" src="https://static.igem.org/mediawiki/2015/6/60/EPF_Lausanne_Home5.png" alt="Second slide"> |
| − | | + | |
| − | <div id="Bind" class="tab-pane fade">
| + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-10 col-md-offset-1 text-justify"> | + | |
| − | <h3>dCas9 binding models</h3> | + | |
| − | <h4>dCas9-\(\omega\) and dCas9-VP64 structures</h4>
| + | |
| − | <p>It is often important to visualize proteins, as their 3-D structure can give information about functionality. Unfortunately, a PDB (Protein Data Bank, [17]) file for dCas9-\(\omega\) or dCas9-VP64 is not available as X-ray cristallography data on this protein are lacking. However, it is possible to extract the \(\omega\) subunit directly from the RNA polymerase (RNAP) and align it with the dCas9 protein structure.</p>
| + | |
| − | | + | |
| − | <p>We will focus here on dCas9-\(\omega\), as for dCas9-VP64 the same conclusions hold. All manipulations are performed with the VMD (Visual Molecular Dynamics, [18]) software and final images are rendered with Pixar's RenderMan rendering engine. We extracted the \(\omega\) subunit from the E. coli RNA polymerase (PDB 3LU0, [19]). The \(\omega\) subunit is then aligned to the dCas9 protein (PDB 4ZT9, [20]) in order to keep the continuity on the DNA sequence. </p>
| + | |
| − | | + | |
| − | <p>The structure we obtained ins presented in the following picture, where we highligted the \(\omega\) subunit (in green) and the gRNA (red for the scaffold, blue for the targeting sequence). The orientation of the \(\omega\) subunit is obviously arbitrary, but we can already get an idea of the size of this protein.</p>
| + | |
| − | | + | |
| − | <center>
| + | |
| − | <figure>
| + | |
| − | <img src=" https://static.igem.org/mediawiki/2015/7/7d/DCas9w.png" alt="dCas9w" style="height:50%;width:50%;" /> | + | |
| − | <figcaption>dCas9-\(\omega\) structure with gRNA. In grey we have dCas9, in red the gRNA scaffold, in blue the gRNA 20bp specificity determinant sequence and in green the \(\omega\) RNAP subunit.</figcaption>
| + | |
| − | </figure>
| + | |
| − | </center>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <p>From the protein structure we can estimate the size of dCas9 on the DNA. We have a length of approximately 80 Å. In E. coli the distance between the activating and inhibiting sequences is of 33bp or 37bp (remember, we have two possible inhibiting sites), while in S. cerevisiae this distance is of 67bp (for the best candidates). Now the length of double stranded DNA is of 3.1 Å per base [22], therefore the distance between the activating and inhibiting sites in E. coli spans from 102 Å to 115 Å while in S. cerevisiae it is 208 Å (for the best candidates).</p>
| + | |
| − | | + | |
| − | <p>As activating and inhibiting sites are 20bp long (62 Å), we see that in E. coli the dCas9-gRNA targeting of one site is not necessarely independent of the state of the other site (occupied or free) while in S. cerevisiae it can be considered as such. </p>
| + | |
| − | | + | |
| − | <h4>Statistical derivation of the Hill's function</h4>
| + | |
| − | <p>In this section we will derive the Hill's function from statistical mechanics calculations of ligand-receptor binding. The following discussion is strongly based on Ref. [1].</p>
| + | |
| − | | + | |
| − | <p>In biology we are often confronted with systems containing large number of interacting particles (small molecules, proteins, DNA and RNA fragments, ...). It is often impossible to describe the system by describing each particle individually but this is not a major problem if we are interested in the average behaviour of the system; the mathematical tool which allows such description is statistical mechanics. Statistical mechanics rely on the concept of microstate which is one particular realization of the microscopic arrangement of the constituents for the problem of interest [1].</p>
| + | |
| − | | + | |
| − | <p>In order to simplify we will consider a lattice model for particles in solution, i.e. we imagine the solution as a series of tiny boxes amongst which we can distribute the ligands [1]. We model here the ligand-receptor binding, where there is one receptor and \(L\) ligands. The number of microstates \(W\) for this system is given by the number of ways \(W_f\) of arranging the \(L\) ligands inside the lattice with a free receptor plus the number of ways \(W_o\) of arranging the \(L-1\) ligands inside the lattice with an occupied receptor:
| + | |
| − | \[
| + | |
| − | W = W_f + W_o = \frac{\Omega!}{L!(\Omega-L)!} + \frac{\Omega!}{(L-1)!(\Omega-L+1)!},
| + | |
| − | \]
| + | |
| − | where \(\Omega\) is the total number of available lattice sites.
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <p>Each microstate has a weight, which is given by the Boltzmann factor (if you are not at ease with the concepts of statistical mechanics, we encourage you to consult Ref. [1] for a very clear and biology-friendly introduction to the subject). We suppose that the energy of one ligand in the solution is \(\epsilon_\text{sol}\) while the energy of a ligand bound to the receptor is \(\epsilon_\text{b}\). We con now write the partition function, which is
| + | |
| − | \[
| + | |
| − | Z = W_f e^{-\beta L\epsilon_\text{sol}} + W_o e^{-\beta [(L-1)\epsilon_\text{sol} + \epsilon_{b}]} = \frac{\Omega!}{L!(\Omega-L)!}e^{-\beta L\epsilon_\text{sol}} + \frac{\Omega!}{(L-1)!(\Omega-L+1)!} e^{-\beta [(L-1)\epsilon_\text{sol} + \epsilon_\text{b}]}.
| + | |
| − | \]
| + | |
| − | The probability to have a ligand bound to the receptor is finally
| + | |
| − | \[
| + | |
| − | p_\text{bound} = \dfrac{\frac{\Omega!}{(L-1)!(\Omega-L+1)!} e^{-\beta [(L-1)\epsilon_\text{sol} + \epsilon_\text{b}]}}{Z}
| + | |
| − | \]
| + | |
| − | This result can be simplified by the assumption that \(L\ll\Omega\), which implies [1]
| + | |
| − | \[
| + | |
| − | \frac{\Omega!}{(\Omega-L)!} \approx \Omega^L.
| + | |
| − | \]
| + | |
| − | This gives finally, with some rearrangement
| + | |
| − | \[
| + | |
| − | p_\text{bound} = \dfrac{\frac{L}{\Omega}e^{-\beta\Delta \epsilon}}{1 + \frac{L}{\Omega}e^{-\beta\Delta \epsilon}},
| + | |
| − | \]
| + | |
| − | where \(\Delta \epsilon = \epsilon_\text{b}- \epsilon_\text{sol}\).
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <p>We were able to find the binding probability of one ligand to a receptor using the tools of statistical physics, but this seems unrelated to the well-known Hill's function. In order to obtain the Hill's function we can write the ligand concentration as
| + | |
| − | \[
| + | |
| − | c = \frac{L}{\Omega V_0},
| + | |
| − | \]
| + | |
| − | where \(V_0\) is the volume of one lattice box. We also introduce a reference concentration \(c_0=1/V_0\). Thus we can write the binding probability as
| + | |
| − | \[
| + | |
| − | p_\text{bound} = \dfrac{\frac{c}{c_0}e^{-\beta\Delta \epsilon}}{1 + \frac{c}{c_0}e^{-\beta\Delta \epsilon}}
| + | |
| − | \]
| + | |
| − | Finally, by defining the association constant
| + | |
| − | \[
| + | |
| − | K_a = \frac{1}{c_0}e^{-\beta\Delta \epsilon}
| + | |
| − | \]
| + | |
| − | we obtain the Hill's function of order 1, i.e.
| + | |
| − | \[
| + | |
| − | H(c) = \frac{K_ac}{1+K_ac} = \frac{c}{K_d + c},
| + | |
| − | \]
| + | |
| − | where
| + | |
| − | \[ K_d = 1/K_a\)\]
| + | |
| − | is the dissociation constant. From this derivation it is clear that the Hill's function \(H(c)\) can be interpreted as the binding probability of ligands present at a concentration \(c\).
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <center>
| + | |
| − | <figure>
| + | |
| − | <img src="https://static.igem.org/mediawiki/2015/9/9b/Hill.png" alt="Hill" style="height:60%;width:60%;" />
| + | |
| − | <figcaption>Hill's function for different values of \(K_d\).</figcaption>
| + | |
| − | </figure>
| + | |
| − | </center></br>
| + | |
| − | | + | |
| − | <h4>Binding probability and interactions</h4>
| + | |
| − | <p>Hill's function gives a ligand/receptor binding probability and will be used to model the mRNA or gRNA transcription caused by the dCas9-gRNA in the case of simple activation or inhibition. In the complex case where activation and inhibition compete we have to take into account a possible interaction between the two dCas9-gRNA complexes: the presence of one complex on the activating/inhibiting sites can partially (or totally) prevent the attachment of the other complex. This is in particular important in E. Coli, where the distance between the activating and inhibiting sites is of 33-37bp bp (in S. s. cerevisiae this distance is as long as 67bp, for the best candidates). The partition function of such system is given by
| + | |
| − | \[
| + | |
| − | Z = 1 + K_a[\text{dCas9-gRNA}_a] + K_a[\text{dCas9-gRNA}_i] + K_a^2[\text{dCas9-gRNA}_a][\text{dCas9-gRNA}_i]e^{-\beta J}
| + | |
| − | \]
| + | |
| − | where we assumed that the association constant is the same of the activating and inhibiting dCas9-gRNA complexes and where \(J\) is the interaction energy between the two.</p>
| + | |
| − | | + | |
| − | <p>
| + | |
| − | If we consider and independent binding, i.e. the complex on the activating and inhibiting sites does not interact \(J=0\), the partition function can be factorized:
| + | |
| − | \[
| + | |
| − | Z_0 = (1+ K_a[\text{dCas9-gRNA}_a])(1+ K_a[\text{dCas9-gRNA}_i]).
| + | |
| − | \]
| + | |
| − | From the partition function we can easily obtain the binding probability of activating and inhibiting complexes:
| + | |
| − | \[
| + | |
| − | p_a = \frac{K_a[\text{dCas9-gRNA}_a]}{Z_0} = \frac{H([\text{dCas9-gRNA}_a])}{1+K_a[\text{dCas9-gRNA}_i]}
| + | |
| − | \]
| + | |
| − | and
| + | |
| − | \[
| + | |
| − | p_i = \frac{K_a[\text{dCas9-gRNA}_i]}{Z_0} = \frac{H([\text{dCas9-gRNA}_i])}{1+K_a[\text{dCas9-gRNA}_a]},
| + | |
| − | \]
| + | |
| − | where \(H\) is the simple Hill's function, as well as the probability that nothing is bound to our promoter
| + | |
| − | \[
| + | |
| − | p_b = \frac{1}{Z_0}.
| + | |
| − | \]
| + | |
| − | The hypothesis of independence for the activating and inhibiting site obviously leads to
| + | |
| − | \[
| + | |
| − | p_{ai} = \frac{K_a^2[\text{dCas9-gRNA}_a][\text{dCas9-gRNA}_b]}{Z_0} = H([\text{dCas9-gRNA}_a])H([\text{dCas9-gRNA}_b]),
| + | |
| − | \]
| + | |
| − | where \(H\) is the simple Hill's function. This probability is plotted as a contour plot in the following figure for clarity.
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <center>
| + | |
| − | <figure>
| + | |
| − | <img src="https://static.igem.org/mediawiki/2015/0/0e/Hill2.png" alt="Hill2" style="height:60%;width:60%;" />
| + | |
| − | <figcaption>Probability \(p_{ai}\) in function of the concentration of activating and inhibiting complexes for the non-interacting model (\(J=0\)).</figcaption>
| + | |
| − | </figure>
| + | |
| − | </center>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <p>
| + | |
| − | This considerations allows us to compute the response of an activated/inhibited transistor, for which we will have (using the fact that \(p_b = 1 -p_a - p_i + p_{ai} \), denoting \([A]=[\text{dCas9-gRNA}_a]\) and \([I] =[\text{dCas9-gRNA}_i] \) and setting the inhibited expression level \(\alpha_i\) to zero)
| + | |
| − | \[
| + | |
| − | \alpha_\text{max}p_a + \alpha_\text{b}p_b + \alpha_{ai}p_{ai} =\alpha_b + (\alpha_\text{max}-\alpha_b) \frac{H([A])}{1+K_a[I]} - \alpha_b \frac{H([I])}{1+K_a[A]}+(\alpha_{ai}-\alpha{b})H([A])H([I])
| + | |
| − | \]
| + | |
| − | Again, we can visualize the response of the system to different levels of concentrations of the activating and inhibiting complexes: the response is in this case the production of new gRNAs or mRNA for reporter proteins (output signals).
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <center>
| + | |
| − | <figure>
| + | |
| − | <img src="https://static.igem.org/mediawiki/2015/a/ad/Independent_binding.png" alt="Hill2" style="height:60%;width:60%;" />
| + | |
| − | <figcaption></figcaption>
| + | |
| − | </figure>
| + | |
| − | </center>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <p>If we consider a completely exclusive binding (i.e. either the activator or the inhibitor complex is attached to the promoter), in our model we have to set \(J\to\infty\) (i.e. the interaction energy between two complexes goes to infinity). In this case the last term of \(Z\) wanishes and the partition function of our system is simply
| + | |
| − | \[
| + | |
| − | Z_{\infty} = 1 + K_a[\text{dCas9-gRNA}_a] + K_a[\text{dCas9-gRNA}_i].
| + | |
| − | \]
| + | |
| − | Again, it is easy to compute binding probabilities. We have
| + | |
| − | \[
| + | |
| − | p_a = \frac{K_a[\text{dCas9-gRNA}_a]}{Z_{\infty}} = \frac{K_a[\text{dCas9-gRNA}_a]}{1 + K_a[\text{dCas9-gRNA}_a] + K_a[\text{dCas9-gRNA}_i]}
| + | |
| − | \]
| + | |
| − | and
| + | |
| − | \[
| + | |
| − | p_i = \frac{K_a[\text{dCas9-gRNA}_a]}{Z_{\infty}} = \frac{K_a[\text{dCas9-gRNA}_a]}{1 + K_a[\text{dCas9-gRNA}_a] + K_a[\text{dCas9-gRNA}_i]}.
| + | |
| − | \]
| + | |
| − | Obviously, we have
| + | |
| − | \[
| + | |
| − | p_{ai} = \lim_{J\to\infty} \frac{K_a^2[\text{dCas9-gRNA}_a][\text{dCas9-gRNA}_i]e^{-\beta J}{Z(J)} = 0.
| + | |
| − | \]
| + | |
| − | | + | |
| − | This gives us the response of activation and inhibition when the binding is exclusive (\(p_{ai} = 0\) and again \(\alpha_i=0\)):
| + | |
| − | \[
| + | |
| − | \alpha_{max}p_a + \alpha_bp_b = \alpha_maxp_a + \alpha_b(1-p_a-p_i) = (\alpha_max-\alpha_b)p_a + \alpha_b (1-p_i).
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <center>
| + | |
| − | <figure>
| + | |
| − | <img src="https://static.igem.org/mediawiki/2015/e/e7/Exclusive_binding.png" alt="Hill2" style="height:60%;width:60%;" />
| + | |
| − | <figcaption></figcaption>
| + | |
| − | </figure>
| + | |
| − | </center>
| + | |
| − | | + | |
| − | <p>In the case where the interaction between the two dCas9-gRNA complexes is not negligible (because the activating/inhibiting binding sites are too close or because the persistence length of the double stranded DNA changes significantly when it is open by dCas9) we have \(J\neq 0\). The situation is more complicated but we can still computing the binding probabilities using the total partition function \(Z\). However, in this case we will have an additional non-trivial parameter to estimate which is the interaction energy \(J\).</p>
| + | |
| − | | + | |
| | </div> | | </div> |
| − | </div>
| + | |
| − | </div>
| + | <img class="img-responsive center-block" src="https://static.igem.org/mediawiki/2015/4/4b/EPF_Lausanne_Home2.png" alt="Third slide"> |
| − | | + | |
| − | <div id="Ass" class="tab-pane fade">
| + | |
| − | | + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-10 col-md-offset-1 text-justify">
| + | |
| − | <h3>Assumptions</h3>
| + | |
| − | <p>Modelers of biophysical system often have a difficult mission. They must strike a compromise between developing a very detailed and accurate model and producing a simplistic one that may be easily analyzed and compared to experimental data.</p>
| + | |
| − | | + | |
| − | <p>Developing model implies making a certain number of simplifications and assumptions to enable it to conform to reality. In this section we will keep track of the assumptions we made in order to clarify our model. Since the same system may be modeled using different approaches, we will justify our choices and set of assumptions.</p>
| + | |
| − | | + | |
| − | <p>The most important assumption underlying our kinetic model is the fact that the concentration of a given species does not depends on spatial coordinates, i.e. it is the same in every region of the cell. This assumption is quite bold but is a common approach in the literature and usually produces accurate results [1]. The validity of this assumption is limited by the small number of molecules present in the cell and localization in membranes or particular organels. In some cases it may also be necessary to consider the stochastic behavior of individual trajectories rather than global averages [1].</p>
| + | |
| − | | + | |
| − | <p>One of the challenges we faced while building the model was the lack of readily available kinetic constants. Since dCas9 is a newly discovered gene regulation technology [2], gRNA/dCas9 and dCas9-dCas9/DNA binding/unbinding kinetics are still under investigation. One may imagine that the binding/unbinding constants are somewhat related to the gRNA sequence given the different chemical properties of nucleotide sequences. However, we will consider binding/unbinding constants to be gRNA-independent. For the gRNA/dCas9 interaction, this assumption is justified by the fact that the gRNA scaffold is always the same. For the gRNA+dCas9/DNA interaction, we can justify this hypothesis by thinking of an average nucleotide composition, as our synthetic sequences are randomly generated</p>
| + | |
| − | | + | |
| − | <p>dCas9 degradation is a fundamental process in our system. Since high levels of dCas9 are toxic for the cell [3], a constantly varying dCas9 population is required for a signal to propagate from one gate to another (remember, the output of a gate is a gRNA which will bind to a free dCas9 in order to propagate the signal to the next gate, cf. <a href="https://2015.igem.org/Team:EPF_Lausanne/Description" target="_blank">Project Description</a>). </br> We can imagine three different types of degradation for the gRNA/dCas9 complex : degradation of the whole complex, dCas9 detaching from its gRNA and the degradation of the gRNA's targeting sequence (resulting in a non-functional but occupied dCas9). We will neglect the last possibility since information about such mechanism are laking. In addition, we assumed that this degradation rate of the whole complex is the same of gRNA-free dCas9.</p>
| + | |
| − | | + | |
| − | <p>dCas9 and GFP degradation are slow []. For these proteins we will take into account only the dilution, i.e. the concentration diminution caused by cell division.</p>
| + | |
| − | | + | |
| − | <p>In our project, the dCas9/gRNA complex is used as a transcription factor. It may alternatively activate or inhibit a targeted promoter. Activation and inhibition processes are modeled using fist-order Hill functions: the Hill function is interpreted as the probability of our dCas9-gRNA complex being bound to the promoter [1]. In order to use this approach, we assume implicitly that the number of dCas9-gRNA binding sites is much smaller than the number of dCas9-gRNA present in our system.
| + | |
| − | </p>
| + | |
| − | | + | |
| − | | + | |
| − | <p>Summary
| + | |
| − | <div align="left">
| + | |
| − | <li>Concentrations depend only on time due to instantaneous diffusion</li>
| + | |
| − | <li>dCas9 binding/unbinding is not dependent on the gRNA's sequence</li>
| + | |
| − | <li>For dCas9 and GFP, \(\gamma_\text{degradation}\ll\gamma_\text{dilution}\)</li>
| + | |
| − | <li>The intracellular number of promoters is constant over time</li>
| + | |
| − | <li>Promotor strength is modeled by an Hill's function, with an Hill's coefficient close to one </li>
| + | |
| − | <li>dCas9/gRNA unbinding is very slow, such that \(D_\text{dCas9}\ll 1\)</li>
| + | |
| − | </div>
| + | |
| − | </p>
| + | |
| | </div> | | </div> |
| − | </div>
| + | <div class="item"> |
| − | </div>
| + | <img class="img-responsive center-block" src="https://static.igem.org/mediawiki/2015/9/9b/EPF_Lausanne_Home3.png" alt="Fourth slide"> |
| − | | + | |
| − | <div id="Eq" class="tab-pane fade">
| + | |
| − | | + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-10 col-md-offset-1 text-justify"> | + | |
| − | <h3>Equations</h3> | + | |
| − | <h4>Activation</h4>
| + | |
| − | <p>Our activation model consists of a simple transistor that takes a gRNA/dCas9 complex as an input (A) and produces a gRNA (C). The gRNA/dCas9 complex enhances the production of the output C, which is otherwise produced basally. In our experimental setup, the output C is used to enhance the production of GFP to enable a quantitative measurement of the activation (with respect to the basal expression).</p>
| + | |
| − | | + | |
| − | <p>
| + | |
| − | dCas9 is constitutively produced from a low copy plasmid and its degradation is proportional to its concentration. The population of unbound dCas9 is also affected by the binding between dCas9 and a gRNA. The unbinding of this two species is neglected (see justification above).
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{dCas9}] = \alpha_\text{dCas9} - (\gamma_\text{mRNA}+\gamma) [\text{mRNA}_\text{dCas9}]
| + | |
| − | \]
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9}] = \beta_\text{dCas9}[\text{mRNA}_\text{dCas9}] - \gamma [\text{dCas9}] + D_\text{dCas9}[\text{dCas9-gRNA}] - R_\text{dCas9}[\text{dCas9}][\text{gRNA}]
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <p>
| + | |
| − | gRNA is produced by an inducible promoter. gRNAs are degraded proportionally to their concentration. Unbound gRNAs may also bind to a free dCas9 protein. As stated previously, the dCas9/gRNA complex is degraded as a whole (at the same rate as unbound dCas9 degradation). Therefore, there is no gRNA production that results from the complex's dissociation.
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}] + D_\text{dCas9}[\text{dCas9-gRNA}] - R_{dCas9}[\text{dCas9}][\text{gRNA}]
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <p>
| + | |
| − | dCas9/gRNA complexes are our gene regulatory units: depending on the targeted site of a promoter, these complex can enhance or inhibit gene transcription. To test activation, gRNA sequences were generated to exclusively target activating sites. In this case, the binding of dCas9/gRNA to the promotor enhances transcription, which is otherwise in a basal expression. The binding of a dCas9/gRNA to a promoter creates an activated transistor which is otherwise in a basal state.
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}] - D_\text{dCas9}[\text{dCas9-gRNA}] - \gamma[\text{dCas9-gRNA}]
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | <p>
| + | |
| − | Our simple transistor (used to simulate activation) can be found in two states: activated (\(Ta\)) or basal (\(Tb\)). The switch between basal and activated states is obtained by the binding/unbinding of the dCas9/gRNA complex and is represented by an Hill function, which gives the probability of a dCas9/gRNA complex being attached to the promotor [1]. In order to assess the functionality of our transistor and the targeting of the dCas9/gRNA complex, we used a measurable output: green fluorescent protein (GFP):
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_{GFP,max}\frac{[\text{dCas9-gRNA}]}{K_\text{DNA} + [\text{dCas9-gRNA}]} + \alpha_\text{GFP,b} \left( 1 - \frac{[\text{dCas9-gRNA}]}{K_\text{DNA} + [\text{dCas9-gRNA}]} \right) - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}],
| + | |
| − | \]
| + | |
| − | | + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{GFP}] = \beta_\text{GFP} [\text{mRNA}_\text{GFP}] - (\gamma_{GFP}+\gamma)[\text{GFP}].
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | <table cellspacing='0' style="width:80%">
| + | |
| − | <thead>
| + | |
| − | <tr>
| + | |
| − | <th>Equations for activation</th>
| + | |
| − | </tr>
| + | |
| − | </thead>
| + | |
| − | <tbody>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{dCas9}] = \alpha_\text{dCas9} - (\gamma_\text{mRNA}+\gamma) [\text{mRNA}_\text{dCas9}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9}] = \beta_\text{dCas9}[\text{mRNA}_\text{dCas9}] - \gamma [\text{dCas9}] + D_\text{dCas9}[\text{dCas9-gRNA}] - R_\text{dCas9}[\text{dCas9}][\text{gRNA}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}] + D_\text{dCas9}[\text{dCas9-gRNA}] - R_{dCas9}[\text{dCas9}][\text{gRNA}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}] - D_\text{dCas9}[\text{dCas9-gRNA}] - \gamma[\text{dCas9-gRNA}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_{GFP,max}\frac{[\text{dCas9-gRNA}]}{K_\text{DNA} + [\text{dCas9-gRNA}]} + \alpha_\text{GFP,b} \left( 1 - \frac{[\text{dCas9-gRNA}]}{K_\text{DNA} + [\text{dCas9-gRNA}]} \right) - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}],
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{GFP}] = \beta_\text{GFP} [\text{mRNA}_\text{GFP}] - (\gamma_{GFP}+\gamma)[\text{GFP}].
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | </tbody>
| + | |
| − | </table>
| + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <h4>Inhibition</h4>
| + | |
| − | <p>Inhibition works similarly to activation, with the difference of the targeting site of the dCas9/gRNA complex. In the case of activation, the dCas9/gRNA complex targets a sequence on DNA such that the RNA polymerase (RNAP) recruiting unit (\(\omega\) unit in E. Coli and VP64 in yeast) is close to the RNAP binding site: the recruiting unit enhance RNAP binding and therefore gene transcription. In the case of inhibition, the dCas9/gRNA targeting sequence on DNA is so close to the RNAP binding site that the RNAP is not able to bind anymore; this steric inhibition prevents gene transcription.<p>
| + | |
| − | | + | |
| − | <p>If we interpret the Hill function as a binding probability [1], in the case of inhibition we have that a basal expression is possible when nothing is bound to the promotor. Thus the equation of \(\text{mRNA}_\text{GFP}\) production is now the following:
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_{GFP,b}\left( 1 - \frac{[\text{dCas9-gRNA}]}{K_\text{DNA} + [\text{dCas9-gRNA}]}\right) - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}].
| + | |
| − | \]
| + | |
| − | This means that at low concentrations of \(\text{dCas9-gRNA}\) we have a basal expression, while at high concentrations the production of \(\text{mRNA}_\text{GFP}\) is extremely low.</p>
| + | |
| − | | + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | <table cellspacing='0' style="width:80%">
| + | |
| − | <thead>
| + | |
| − | <tr>
| + | |
| − | <th>Equations for inhibition</th>
| + | |
| − | </tr>
| + | |
| − | </thead>
| + | |
| − | <tbody>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{dCas9}] = \alpha_\text{dCas9} - (\gamma_\text{mRNA}+\gamma) [\text{mRNA}_\text{dCas9}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9}] = \beta_\text{dCas9}[\text{mRNA}_\text{dCas9}] - \gamma [\text{dCas9}] + D_\text{dCas9}[\text{dCas9-gRNA}] - R_\text{dCas9}[\text{dCas9}][\text{gRNA}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}] + D_\text{dCas9}[\text{dCas9-gRNA}] - R_{dCas9}[\text{dCas9}][\text{gRNA}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}] - D_\text{dCas9}[\text{dCas9-gRNA}] - \gamma[\text{dCas9-gRNA}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_{GFP,b}\left( 1 - \frac{[\text{dCas9-gRNA}]}{K_\text{DNA} + [\text{dCas9-gRNA}]}\right) - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}].
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{GFP}] = \beta_\text{GFP} [\text{mRNA}_\text{GFP}] - (\gamma_{GFP}+\gamma)[\text{GFP}].
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | </tbody>
| + | |
| − | </table>
| + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <h4>Chainability</h4>
| + | |
| − | <p>Chainability of different transistor-like elements is the key points of our project. In fact, it is only by chaining different transistor that we can create complex logic circuits. In order to test experimentally the chainability of our biological transistors, we added an intermediate step to the production of GFP by activation: a first gRNA (\(gRNA_A\)) bound to dCas9 target a promoter which produces a second gRNA (\(gRNA_B\)) which in turn can activate the production of GFP.</p>
| + | |
| − | | + | |
| − | <p>Compared to simple activation, our model changes in the following ways. First of all we have now two distinct gRNAs in our system (\(\text{gRNA}_A\) and \(\text{gRNA}_B\)); this obviously imply the presence of two possible dCas9/gRNA complexes:
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}_A] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}_A] - D_\text{dCas9}[\text{dCas9-gRNA}_A] - \gamma[\text{dCas9-gRNA}_A]
| + | |
| − | \]
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}_B] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}_B] - D_\text{dCas9}[\text{dCas9-gRNA}_B] - \gamma[\text{dCas9-gRNA}_B]
| + | |
| − | \]
| + | |
| − | For the production of the first gRNA, i.e. \(\text{gRNA}_A\), is unchanged compared to the activation and inhibition models:
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}_A] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}_A] + D_\text{dCas9}[\text{dCas9-gRNA}_A] - R_{dCas9}[\text{dCas9}][\text{gRNA}_A]
| + | |
| − | \]
| + | |
| − | For the second gRNA, i.e. \(\text{gRNA}_B\), because it is produced thanks to the activating effect of the \(\text{dCas9-gRNA}_A\) complex. Thus, similarly for what we had for the \(\text{mRNA}_\text{GFP}\) production we can write
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}_B] = \alpha_\text{gRNA}\frac{[\text{dCas9-gRNA}_A]}{K_\text{DNA} + [\text{dCas9-gRNA}_A]} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}_B]+ D_\text{dCas9}[\text{dCas9-gRNA}_B] - R_{dCas9}[\text{dCas9}][\text{gRNA}_B]
| + | |
| − | \]
| + | |
| − | without forgetting that gRNAs, in contrast to mRNAs, can bind dCas9 to form the dCas9/gRNA complex. Because of these additional reaction, dCas9 population changes as follows:
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9}] = \beta_\text{dCas9}[\text{mRNA}_\text{dCas9}] - \gamma [\text{dCas9}] + D_\text{dCas9}([\text{dCas9-gRNA}_A]+[\text{dCas9-gRNA}_B]) - R_\text{dCas9}[\text{dCas9}]([\text{gRNA}_A]+[\text{gRNA}_B]).
| + | |
| − | \]
| + | |
| − | Finally, GFP production is modulated by \(\text{gRNA}_B\), therefore
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_{GFP,max}\frac{[\text{dCas9-gRNA}_\text{B}]}{K_\text{DNA} + [\text{dCas9-gRNA}_\text{B}]} + \alpha_\text{GFP,b} \left( 1 - \frac{[\text{dCas9-gRNA}_\text{B}]}{K_\text{DNA} + [\text{dCas9-gRNA}_\text{B}]}\right) - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}],
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | | + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | <table cellspacing='0' style="width:80%">
| + | |
| − | <thead>
| + | |
| − | <tr>
| + | |
| − | <th>Equations for chainability</th>
| + | |
| − | </tr>
| + | |
| − | </thead>
| + | |
| − | <tbody>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{dCas9}] = \alpha_\text{dCas9} - (\gamma_\text{mRNA}+\gamma) [\text{mRNA}_\text{dCas9}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9}] = \beta_\text{dCas9}[\text{mRNA}_\text{dCas9}] - \gamma [\text{dCas9}] + D_\text{dCas9}([\text{dCas9-gRNA}_A]+[\text{dCas9-gRNA}_B]) - R_\text{dCas9}[\text{dCas9}]([\text{gRNA}_A]+[\text{gRNA}_B])
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}_A] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}_A] + D_\text{dCas9}[\text{dCas9-gRNA}_A] - R_{dCas9}[\text{dCas9}][\text{gRNA}_A]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}_A] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}_A] - D_\text{dCas9}[\text{dCas9-gRNA}_A] - \gamma[\text{dCas9-gRNA}_A]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}_B] = \alpha_\text{gRNA}\frac{[\text{dCas9-gRNA}_A]}{K_\text{DNA} + [\text{dCas9-gRNA}_A]} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}_B]+ D_\text{dCas9}[\text{dCas9-gRNA}_B] - R_{dCas9}[\text{dCas9}][\text{gRNA}_B]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}_B] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}_B] - D_\text{dCas9}[\text{dCas9-gRNA}_B] - \gamma[\text{dCas9-gRNA}_B]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_{GFP,max}\frac{[\text{dCas9-gRNA}_\text{B}]}{K_\text{DNA} + [\text{dCas9-gRNA}_\text{B}]} + \alpha_\text{GFP,b} \left( 1 - \frac{[\text{dCas9-gRNA}_\text{B}]}{K_\text{DNA} + [\text{dCas9-gRNA}_\text{B}]}\right) - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}],
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{GFP}] = \beta_\text{GFP} [\text{mRNA}_\text{GFP}] - (\gamma_{GFP}+\gamma)[\text{GFP}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | </tbody>
| + | |
| − | </table>
| + | |
| − | | + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <h4>Activation and inhibition</h4>
| + | |
| − | <p>Activation and inhibition can be present at the same time, since dCas9 can target different promoter sites depending on the gRNA> In S. cerevisiae the inhibition dominate the activation [23], while in E. coli this has not been tested to our knowledge. Our experimental results shows that in E. coli the inhibition is not dominant as in S. cerevisiae as the distance between inhibiting and activating promoter binding sites is smaller and dCas9-dCas9 interaction play a role.</p>
| + | |
| − | | + | |
| − | <p>In order to model activation and inhibition in S. cerevisiae and E. coli, we will use two extrema of the binding model developed in the <a href="#Bind" target="blank">Binding</a> section. For S. cerevisiae we will swt \(J=0\) as we assume no interaction between two dCas9 bound to the same promoter, while in E. coli we will use \(J=\infty\), in order to allow the attachement of only one dCas9 at a time. Obviously, the situation is probably more complex and \(J\) assumes an intermediate value on the interval \([0,\infty]\), but for simplicity we used only the extreme values.</p>
| + | |
| − | | + | |
| − | <p>In our system we now have to distinguish between gRNAs which target the inhibiting sequence (which we call \(gRNA_I\)) and gRNAs which target the activating sequence (which we call \(gRNA_A\)). The transcriptional response of our transistor targeted by activating and inhibiting complexes is given by
| + | |
| − | \[
| + | |
| − | \alpha_\text{max}p_a + \alpha_bp_b + \alpha_{ai}p_{ai}
| + | |
| − | \]
| + | |
| − | with the implicit assumption that \(\alpha_i \approx 0\). The probabilities \(p_a\), \(p_b\) and \(p_{ai}\) are defined in the <a href="#Bind" tarket="blank">Binding</a> section and depends on the system under investigation (basically, on the value of \(J\)). This gives finally
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_\text{max}p_a + \alpha_bp_b + \alpha_{ai}p_{ai} - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}].
| + | |
| − | \]
| + | |
| − | </p>
| + | |
| − | | + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | <table cellspacing='0' style="width:80%">
| + | |
| − | <thead>
| + | |
| − | <tr>
| + | |
| − | <th>Equations for activation/inhibition</th>
| + | |
| − | </tr>
| + | |
| − | </thead>
| + | |
| − | <tbody>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{dCas9}] = \alpha_\text{dCas9} - (\gamma_\text{mRNA}+\gamma) [\text{mRNA}_\text{dCas9}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9}] = \beta_\text{dCas9}[\text{mRNA}_\text{dCas9}] - \gamma [\text{dCas9}] + D_\text{dCas9}([\text{dCas9-gRNA}_A]+[\text{dCas9-gRNA}_I]) - R_\text{dCas9}[\text{dCas9}]([\text{gRNA}_A]+[\text{gRNA}_I])
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}_A] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}_A] + D_\text{dCas9}[\text{dCas9-gRNA}_A] - R_{dCas9}[\text{dCas9}][\text{gRNA}_A]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}_A] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}_A] - D_\text{dCas9}[\text{dCas9-gRNA}_A] - \gamma[\text{dCas9-gRNA}_A]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{gRNA}_I] = \alpha_\text{gRNA} -(\gamma_{mRNA}+\gamma)[\mathit{gRNA}_I] + D_\text{dCas9}[\text{dCas9-gRNA}_I] - R_{dCas9}[\text{dCas9}][\text{gRNA}_I]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{dCas9-gRNA}_I] = R_\text{dCas9} [\text{dCas9}][\text{gRNA}_I] - D_\text{dCas9}[\text{dCas9-gRNA}_I] - \gamma[\text{dCas9-gRNA}_I]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr class="even">
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{mRNA}_\text{GFP}] = \alpha_\text{max}p_a + \alpha_bp_b + \alpha_{ai}p_{ai} - (\gamma_{mRNA}+\gamma) [\text{mRNA}_\text{GFP}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | <tr>
| + | |
| − | <td>
| + | |
| − | \[
| + | |
| − | \frac{d}{dt}[\text{GFP}] = \beta_\text{GFP} [\text{mRNA}_\text{GFP}] - (\gamma_{GFP}+\gamma)[\text{GFP}]
| + | |
| − | \]
| + | |
| − | </td>
| + | |
| − | </tr>
| + | |
| − | </tbody>
| + | |
| − | </table>
| + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <h4>Logic gates</h4>
| + | |
| − | <p>Logic gates and complex systems are designed from bio-transistor. Therefore, if we are able to model activation, inhibition and activation/inhibition of our transistors we can use them in parallel and chain them together in order to create logic gates.</p>
| + | |
| − | | + | |
| | </div> | | </div> |
| − | </div>
| + | |
| − | </div>
| + | <img class="img-responsive center-block" src="https://static.igem.org/mediawiki/2015/1/1a/EPF_Lausanne_Home4.png" alt="Fifth slide"> |
| − | | + | |
| − | <div id="Cst" class="tab-pane fade">
| + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-10 col-md-offset-1 text-justify">
| + | |
| − | <h3>Constants</h3>
| + | |
| − | <h4>Constats summary</h4>
| + | |
| − | <p>The following table summarize the constants used in our model (see <a href="#Eq">Equations</a>). A detailed explanation of the estimation performed, or computations starting from the literature can be found below.</p>
| + | |
| − | | + | |
| − | | + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | <table cellspacing='0' style="width:80%">
| + | |
| − | <thead>
| + | |
| − | <tr>
| + | |
| − | <th>Name</th>
| + | |
| − | <th>Description</th>
| + | |
| − | <th>Value</th>
| + | |
| − | <th>Source</th>
| + | |
| − | </tr>
| + | |
| − | </thead>
| + | |
| − | <tbody>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\alpha_{dCas9}\) (E. coli)</td>
| + | |
| − | <td>mRNA encoding dCas9 production</td>
| + | |
| − | <td>83 (nM/min)</td>
| + | |
| − | <td>Estimated</td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\alpha_{gRNA}\) (E. coli)</td>
| + | |
| − | <td>gRNA production</td>
| + | |
| − | <td>498 (nM/min)</td>
| + | |
| − | <td>Estimated</td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\alpha_{GFP,b}\) (E. coli)</td>
| + | |
| − | <td>mRNA encoding GFP production</td>
| + | |
| − | <td>83 (nM/min)</td>
| + | |
| − | <td>Estimated</td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\alpha_{dCas9}\) (S. cerevisiae)</td>
| + | |
| − | <td>mRNA encoding dCas9 production</td>
| + | |
| − | <td></td>
| + | |
| − | <td></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\alpha_{gRNA}\) (S. cerevisiae)</td>
| + | |
| − | <td>gRNA production</td>
| + | |
| − | <td></td>
| + | |
| − | <td></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\alpha_{GFP}\) (S. cerevisiae)</td>
| + | |
| − | <td>mRNA encoding GFP production</td>
| + | |
| − | <td></td>
| + | |
| − | <td></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\beta_{dCas9}\) (E. coli)</td>
| + | |
| − | <td>dCas9 production from mRNA</td>
| + | |
| − | <td>2 (1/min)</td>
| + | |
| − | <td><a href="http://ccdb.wishartlab.com/CCDB/">E. coli stats</a></p></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\beta_{dCas9}\) (S. cerevisiae)</td>
| + | |
| − | <td>dCas9 production from mRNA</td>
| + | |
| − | <td></td>
| + | |
| − | <td></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\beta_{GFP}\) (E. coli)</td>
| + | |
| − | <td>GFP production from mRNA</td>
| + | |
| − | <td>2 (1/min)</td>
| + | |
| − | <td><a href="http://ccdb.wishartlab.com/CCDB/">E. coli stats</a></p></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\beta_{GFP}\) (S. cerevisiae)</td>
| + | |
| − | <td>GFP production from mRNA</td>
| + | |
| − | <td> </td>
| + | |
| − | <td></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\gamma_{mRNA}\) (E. coli)</td>
| + | |
| − | <td>mRNA degradation</td>
| + | |
| − | <td>0.2 (1/min)</td>
| + | |
| − | <td><a href="http://www.pnas.org/content/101/9/2758.abstract" target="_blank">Bernstein et al. [5]</a></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\gamma_{mRNA}\) (S. cerevisiae)</td>
| + | |
| − | <td>mRNA degradation</td>
| + | |
| − | <td>0.03 (1/min)</td>
| + | |
| − | <td><a href="http://www.pnas.org/content/99/9/5860.abstract" target="_blank">Wang et al. [6]</a></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\gamma_{GFP}\) (E. coli)</td>
| + | |
| − | <td>GFP degradation rate</td>
| + | |
| − | <td>0.03 (1/h)</td>
| + | |
| − | <td><a href="http://bionumbers.hms.harvard.edu/bionumber.aspx?&id=105191&ver=0" target="_blank">BioNumber 105191</a></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(\gamma\) (E. coli)</td>
| + | |
| − | <td>Dilution rate</td>
| + | |
| − | <td>0.02 (1/min)</td>
| + | |
| − | <td><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736669/">Kumar and Libchaber [14]</a></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(\gamma\) (S. cerevisiae)</td>
| + | |
| − | <td>Dilution rate</td>
| + | |
| − | <td>0.69 (1/h)</td>
| + | |
| − | <td>BioNumber 108255</td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr>
| + | |
| − | <td>\(K_{dCas9}\)</td>
| + | |
| − | <td>dCas9 and gRNA dissociation constant</td>
| + | |
| − | <td> 10 (nM)</td>
| + | |
| − | <td><a href="http://www.pnas.org/content/112/10/2984.abstract" target="_blank">Wright et al. [11] </a></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | <tr class="even">
| + | |
| − | <td>\(K_{DNA}\)</td>
| + | |
| − | <td>dCas9/gRNA and dsDNA dissociation constant</td>
| + | |
| − | <td>0.04 (nM)</td>
| + | |
| − | <td><a href="http://www.nature.com/nature/journal/v516/n7530/full/nature13769.html?WT.ec_id=NATURE-20141211" target="_blank">O'Connell et al. [10]</a></td>
| + | |
| − | </tr>
| + | |
| − | | + | |
| − | </tbody>
| + | |
| − | </table>
| + | |
| − | </br>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | <h4>mRNA and gRNA production/degradation rates</h4>
| + | |
| − | <p>For mRNA degradation we considered the mean half-life of Refs. [5-6] and subsequently computed the degradation rate. In Ref. [6] the mean half-life is explicitly stated, while we computed ourself the mean half-life of Ref. [5] for different E. Coli strains. Note that for an exponential decay, the half-life \(t_{1/2}\) is linked to the lifetime \(\tau\) by
| + | |
| − | \[
| + | |
| − | t_{1/2} = \tau \log(2)
| + | |
| − | \]
| + | |
| − | and the lifetime \(\tau\) is in turn linked to the decay constant \(\Gamma\) by
| + | |
| − | \[
| + | |
| − | \Gamma = \frac{1}{\tau}.
| + | |
| − | \]</p>
| + | |
| − | | + | |
| − | <p>For gRNAs we use the same degradation rate of mRNAs.</p>
| + | |
| − | | + | |
| − | <p>The estimation of mRNA/gRNA production rates is more complicated as it depends on promotor characteristics. Here we assume for simplicity that all promotors are of the same kind, the only difference being the number of copies of the plasmid they are in (low-copy, medium-copy, and high-copy). We assume that within a single cell we have 5, 30 and 300 copies of low-, midium- and high-copy plasmids respectively. The promotor we then considered the difference between a strong and weak promoters. I E. coli for a strong promoter transcription starts every 6 seconds, while for a weak promotor it starts only every 35 seconds [12]: this means that the production rate is of 10 or 1.7 mRNA per minute. Now, if we suppose that the cell volume for E. coli is approximately 1µm<sup>3</sup> and in S. cerevisiae is 60µm<sup>3</sup> [1] we can compute the production rate of mRNAs within the whole cell. We have that GFP and dCas9 are encoded in a low-copy plasmid, while mRNAs are encoded in a medium-copy plasmid.
| + | |
| − | | + | |
| − | <h4>dCas9 and GFP production/degradation rates</h4>
| + | |
| − | <p>For E. Coli, we found an polipeptide chain elongation rate of 12-21 amino acids per second (BioNumber 100059, [8]). Since the DNA coding for dCas9 fused with the \(\omega\) subunit is 4374bp (see BioBrick LINK), the total number of amino acids composing the protein is 1458. This gives finally a production rate of 0.49-0.86 protein transcript per minute.</p>
| + | |
| − | | + | |
| − | <p>In S. cerevisiae, the polipeptide chain elongation rate is estimated to be 5.5-9.3 amino acids per second [9]. Since the DNA coding for dCas9 fused with the VP64 subunit is 4323bp (see BioBrick LINK), we find an production rate of 0.23-0.39 protein transcript per minute.</p>
| + | |
| − | | + | |
| − | <p>However, the chain elongation gives only an initial lag and thus it will be neglected in our model; what is important is the rate of transcription initiation, which can be found in Ref. [12] for E. coli and in Ref. [] for S. cerevisiae.</p>
| + | |
| − | | + | |
| − | <p>In order to find GFP production rates, we follow exactly the same procedure we used for dCas9. The GFP used in E. coli is 717bp, while the GFP used in S. cerevisiae is 714bp.</p>
| + | |
| − | | + | |
| − | <p>For GFP degradation we consider the GFP(mut3) half-life time (BioNumber 105191) and we computed the degradation rate in the same way we did for mRNAs. Since GFP degradation rate is slow, it will be neglected and we will consider only the dilution rate. Dilution is estimated from the half-life of our organism. For E. coli we have a division every 40 min [14], while for S. cerevisiae we have a division every 1-2 hours (BioNumber 108255). Note from our equation that the dilution rate is added at all degradation rates.</p>
| + | |
| − | | + | |
| − | <p>Fod dCas9 we weren't able to find a satisfactory degradation rate. However, it turns out that dCas9 degrade slowly [13] and again we decided to neglect this degradation compared to dilution. </p>
| + | |
| | </div> | | </div> |
| | </div> | | </div> |
| | + | <a href="#carousel-home" class="left carousel-control" data-slide="prev"> |
| | + | <span class="icon-prev"></span> |
| | + | </a><!-- end left control --> |
| | + | <a href="#carousel-home" class="right carousel-control" data-slide="next"> |
| | + | <span class="icon-next"></span> |
| | + | </a> |
| | </div> | | </div> |
| | | | |
| − | <div id="Sim" class="tab-pane fade">
| |
| | | | |
| − | <div class="row">
| + | <section id="features"> |
| − | <div class=" col- md-10 col-md-offset-1 text-justify"> | + | |
| − | <h3>Results</h3>
| + | <img src="https://static.igem.org/mediawiki/2015/f/f6/EPF_Lausanne_Home_Button.png" alt="Take a tour" usemap="#TakeTour"> |
| − | <h4>Activation and inhibition in E. coli</h4>
| + | |
| − | <p>After finding in the literature or estimating all the parameters of our system, we performed the first simulations.</p>
| + | |
| | | | |
| − | <center>
| + | <map name="TakeTour"> |
| − | <figure>
| + | <area shape="circle" coords="162,250,105" alt="Project" href="https://2015.igem.org/Team:EPF_Lausanne/Project/Description"> |
| − | <img src="https://static.igem.org/mediawiki/2015/a/ad/Activation_Ecoli.png" alt="dCas9w" style="height:48%;width:48%;" />
| + | <area shape="circle" coords="452,120,95" alt="Design" href="https://2015.igem.org/Team:EPF_Lausanne/Design"> |
| − | <img src="https://static.igem.org/mediawiki/2015/8/8e/Inhibition_Ecoli.png" alt="dCas9w" style="height:48%;width:48%;" />
| + | <area shape="circle" coords="1002,160,110" alt="Results" href="https://2015.igem.org/Team:EPF_Lausanne/Results"> |
| − | <figcaption>Activation and inhibition in E. coli.</figcaption>
| + | <area shape="circle" coords="642,360,160" alt="Tour" href="https://2015.igem.org/Team:EPF_Lausanne/Project/Description"> |
| − | </figure>
| + | <area shape="circle" coords="962,540,105" alt="Modeling" href="https://2015.igem.org/Team:EPF_Lausanne/Modeling"> |
| − | </center>
| + | <area shape="circle" coords="352,560,120" alt="Practices" href="https://2015.igem.org/Team:EPF_Lausanne/Practices"> |
| − | | + | <area shape="circle" coords="1154,477,50" alt="meetus" href="https://2015.igem.org/Team:EPF_Lausanne/Team/Meet"> |
| − | <h5>Concentrations range</h5>
| + | </map> |
| − | <p>As our parameters were estimated roughly or taken from different papers published over many years, we have analyze carefully the results of our model. Do GFP concentration in the range of nM make sense? The total number of proteins in E. coli cells is 2x10<sup>6</sup>, while in Yeast cells it reaches 50x10<sup>6</sup> [15]. Using the known volume of E. coli and S. cerevisiae, which is 1µm<sup>3</sup> and 60µm<sup>3</sup> respectively [1], we can compute the protein concentration in µM: for E. coli we have 3x10<sup>3</sup> µM, while for S. cerevisiae we have 80x10<sup>3</sup> µM. These estimations are in good accord with our simulation, where the final GFP concentration in the activation model contribute to 1% of the total protein concentration.</p>
| + | |
| − | | + | |
| − | <p>From the simulation we see that the ratio between proteins and gRNAs (included GFP, when espressed) is very large, i.e. proteins outnumber gRNAs. This behaviour is confirmed experimentally both in E. coli, where this ratio is 1000, and S. cerevisiae, where we reach a ratio of 10'000 [16]. </p>
| + | |
| − | | + | |
| − | <h5>Comparaison with experiments</h5>
| + | |
| − | <p>We immediately see that the time-response out of equilibrium is quite different from what we observed experimentally (cf. LINK). This is mainly caused by the fact that at the beginning of the experiments cells are growing in log phase and therefore the OD600 normalization cause a drop of GFP levels; in contrast our model it at a single cell level and does not suffer of this problem. For this reason we can only compare our model and experimental data at steady state.</p>
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | <p>A/I ~300 ------ A/B ~30</p>
| + | |
| − | | + | |
| − | | + | |
| − | </div>
| + | |
| − | </div> | + | |
| | </div> | | </div> |
| | | | |
| − | <div id="Ref" class="tab-pane fade">
| + | </section> |
| − | | + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-10 col-md-offset-1 text-justify">
| + | |
| − | <h3>References</h3>
| + | |
| − | <h4>Books</h4>
| + | |
| − | <p>[1] R. Phillips et al., Physical Biology of the Cell, Second Edition, Garland Science, 2013.</p>
| + | |
| − | <p>[12] F. Eckstein and D. Lilley, Nucleic Acids and Molecular Biology, vol. 4, Springer, 1990.</p>
| + | |
| − | <p>[16] R. Milo and R. Phillips., Cell biology by the numbers, Draft, 2015.</p>
| + | |
| − | <p>[22] Travers and Buckle, DNA-protein Interactions: A Practical Approach, Oxford University Press, 2000. </p>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | <h4>Articles</h4>
| + | |
| − | <p>[2] L. S. Qi et al., Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression, Cell 152, 1173–1183, 2013.</p>
| + | |
| − | <p>[3] </p>
| + | |
| − | <p>[5] Bernstein et al., Global analysis of Escherichia coli RNA degradosome function using DNA microarrays, PNAS, vol. 101, 2758 –2763, 2004. </p>
| + | |
| − | <p>[6] Wang et al., Precision and functional specificity in mRNA decay, PNAS, vol. 99, 5860 –5865, 2002.</p>
| + | |
| − | <p>[7] </p>
| + | |
| − | <p>[8] Young and Bremer, Polypeptide-Chain-Elongation Rate in Escherichia coli B/r as a Function of Growth Rate, Biochemical Journal, Vol. 160, 185-194, 1976.</p>
| + | |
| − | <p>[9] Bonven and Gulløv, Peptide chain elongation rate and ribosomal activity in Saccharomyces cerevisiae as a function of the growth rate, Molecular and General Genetics, vol. 170, 225-230, 1979.</p>
| + | |
| − | <p>[10] O'Connell et al., Programmable RNA recognition and cleavage by CRISPR/Cas9, Nature, vol. 516, 263-266, 2014.</p>
| + | |
| − | <p>[11] Wright at al., Rational design of a split-Cas9 enzyme complex, PNAS, vol. 112, 2015.</p>
| + | |
| − | <p>[14] Kumar and Libchaber, Pressure and Temperature Dependence of Growth and Morphology of Escherichia coli: Experiments and Stochastic Model, Biophysical Journal, vol. 105, 783-793, 2013.</p>
| + | |
| − | <p>[15] R. Milo, What is the total number of protein molecules per cell volume? A call to rethink some published values, Bioessays, vol. 35, 1050–1055, 2013.</p>
| + | |
| − | <p>[17] H.M. Berman et al., The Protein Data Bank, Nucleic Acids Research, vol. 28, 235-242.</p>
| + | |
| − | <p>[18] Humphrey et al., VMD - Visual Molecular Dynamics, J. Molec. Graphics, 1996, vol. 14, pp. 33-38.</p>
| + | |
| − | <p>[19] Opalka et al., Complete structural model of Escherichia coli RNA polymerase from a hybrid approach, Plos Biol., 2010.</p>
| + | |
| − | <p>[20] Jiang et al., A Cas9-guide RNA complex preorganized for target DNA recognition, Science, vol. 348, 1477-1481, 2015. </p>
| + | |
| − | <p>[23] Farzadfard et al., Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/Cas, ACS Syntethic Biology, vol. 2, 604−613, 2013.</p>
| + | |
| − | </br>
| + | |
| − | | + | |
| − | | + | |
| − | <h4>iGEM Wikis and websites</h4>
| + | |
| − | <p>[4] Team Duke iGEM 2014, <a href="https://2014.igem.org/Team:Duke/Modeling">Wiki</a>.</p>
| + | |
| − | <p>[13] Team Waterloo iGEM 2014, <a href="https://2014.igem.org/Team:Waterloo/Math_Book/CRISPRi">Wiki</a>.</p>
| + | |
| − | <p>[21] <a href="http://ccdb.wishartlab.com/CCDB/">E. coli stats</a></p>
| + | |
| − | | + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | </div> | + | |
| − | </div>
| + | |
| | </body> | | </body> |
| − |
| |
| − | <script src="https://2015.igem.org/common/MathJax-2.5-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
| |
| − |
| |
| | </html> | | </html> |
| − | {{:Team:EPF_Lausanne/Test/footer}} | + | {{:Team:EPF_Lausanne/Footer}} |
